Fukunaga, K., Yoshimura, T., Imachi, H., Kobayashi, T., Saheki, T., Sato, S., Saheki, N., Jiang, W., & Murao, K
Medicare GLP-1 Bridge Model As a reminder, the Bridge Model is a short-term demonstration that CMS is operating to provide eligible Medicare Part D beneficiaries with access to certain specified GLP-1 drugs that started July 1, 2026
And many patients have told me this so that it's a very interesting change that can happen with these medications sometimes, per these patient reports
The cytokine-containing serum group demonstrated superior efficacy compared to other groups in the study
The Phase 2 trial actually tested this directly
Ablation of Sim1 neurons causes obesity through hyperphagia and reduced energy expenditure